Cerevel Therapeutics Holdings, Inc. (CERE) — Analyst outlook / Analyst consensus target is. Based on 16 analyst ratings, the consensus is bullish — 6 Buy, 10 Hold.
The consensus price target is $33.50 (low: $27.00, high: $40.00), representing a downside of 25.5% from the current price $44.96.
CERE Stock — 12-Month Price Forecast
$33.50
▼ -25.49% Downside
Average Price Target
Based on 16 Wall Street analysts offering 12-month price targets for Cerevel Therapeutics Holdings, Inc., the average price target is $33.50, with a high forecast of $40.00, and a low forecast of $27.00.
The average price target represents a -25.49% change from the last price of $44.96.
Highest Price Target
$40.00
Average Price Target
$33.50
Lowest Price Target
$27.00
CERE Analyst Ratings
Hold
Based on 16 analysts giving stock ratings to Cerevel Therapeutics Holdings, Inc. in the past 3 months
